Telomir Pharmaceuticals, Inc. (TELO): SCHEDULE 13G filed Sep 18, 2025

Form type

SCHEDULE 13G

Filing date

Sep 18, 2025

Accession number

0001104659-25-091366

Filer

Telomir Pharmaceuticals, Inc. (CIK 1971532)